SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (390)6/5/2003 2:20:10 PM
From: Icebrg  Read Replies (1) of 1840
 
Targeted Therapies in Lung Cancer:
An interview with Vincent A. Miller, MD
Disclosures

Eric Sabo

Smoking-related adenocarcinoma of the lung is now the most common cause of cancer death in the United States, according to findings presented at the American Society for Clinical Oncology (ASCO). Researchers also confirmed a gradual shift in the histology of lung cancer, with the rise of adenocarcinoma rates corresponding to changes in cigarette design that have allowed smokers to more deeply inhale tar particles.[1]

Until recently, different forms of lung cancer were considered treatable by the same modality. But with the advent of targeted therapies, Dr. Vincent Miller of Memorial Sloan-Kettering Cancer Center in New York says it may be important to look at the different forms of lung cancer, as well as patient characteristics, to determine who will most likely be helped.

"We are starting to see some differences in how patients respond to treatments, at least with targeted therapies," said Dr. Miller. "There will be more attention paid to histology in the coming years."

As researchers at ASCO called for greater efforts to curb smoking, data were also presented on novel agents that may treat both smoking- and nonsmoking-related lung cancer. Dr. Miller discussed these advances with Medscape...

medscape.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News